Esentra 60 mg PFS
226,65$
163,12$
Esentra 60 mg PFS is a vital medication designed to combat osteoporosis, a condition characterized by weakened bones that are susceptible to fractures, particularly in men and postmenopausal women at high risk and who have not found relief from other treatments. This innovative formulation also addresses bone density loss in men undergoing prostate cancer therapy and women receiving treatment for breast cancer, both of which can lead to significant bone weakening. In addition to its primary use, Esentra 60 mg PFS plays a crucial role in minimizing fracture risks in patients with bone cancer and those diagnosed with multiple myeloma, a type of blood cancer. Patients should be aware of potential side effects and consult their healthcare provider to ensure this medication is appropriate for their specific condition. By promoting bone strength and stability, Esentra 60 mg PFS provides a comprehensive approach to managing bone health in vulnerable populations. With its targeted action, it helps restore confidence and mobility in those affected by serious health conditions. Always discuss your treatment plan with a healthcare professional to understand the benefits and risks associated with Esentra 60 mg PFS.
Quantité
Active Pharmaceutical Ingredient
Uses
• Esentra 60 mg pfs is primarily indicated for the treatment of osteoporosis. This condition leads to decreased bone density, making bones fragile and more susceptible to fractures. In particular, it is beneficial for men and postmenopausal women who are at high risk for bone-related injuries. Patients who have not achieved adequate results with other osteoporosis treatments may find Esentra 60 mg pfs to be an effective alternative.
• Another significant use of Esentra 60 mg pfs is in managing osteolytic bone metastases associated with solid tumors. It is especially relevant for men with prostate cancer and women with breast cancer undergoing therapies that may result in bone loss. By addressing the bone deterioration linked to these cancers, Esentra 60 mg pfs helps maintain skeletal integrity. This can be crucial for improving quality of life in patients facing advanced disease.
• Esentra 60 mg pfs serves to support bone health in individuals experiencing conditions that lead to accelerated bone loss. For patients undergoing specific cancer treatments, this medication can help mitigate the negative effects on bone density. By promoting stronger bones, Esentra 60 mg pfs plays a vital role in comprehensive cancer care. Patients may benefit from its protective effects while managing their primary cancer therapies.
Benefits
Esentra 60 mg PFS has been shown to be effective in reducing the risk of fractures in patients with osteoporosis and increasing bone density and strength, resulting in a lower risk of fractures in the spine, hip, and other bones. Esentra 60 mg is effective in reducing the risk of fractures in patients with bone metastases (spread of cancer to the bones).
Side Effects
Anti-osteoporosis Drug Esentra may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Arm or leg pain
• Joint pain
• Muscle or bone pain
• Constipation,
• Abdominal discomfort
• Hair loss
• Skin rash
• Tingling, pain, or numbness that moves down your leg
Common Side Effects
• Upper respiratory tract infection
• Frequent or painful urination, blood in urine, inability to hold urine
• Musculoskeletal
• Severe leg or joint pain
How To Use
Esentra 60 mg PFS can be administered to you subcutaneously (under the skin) by a doctor or nurse. You should also take calcium and vitamin D supplements while being on treatment with Anti-osteoporosis Drug Esentra. Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Esentra 60 mg PFS. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Esentra 60 mg PFS should be used with caution in patients having severe kidney problems. Patients with severe kidney impairment (creatinine clearance < 30 mL/min) or receiving dialysis are at greater risk of developing hypocalcaemia. Consult your doctor before receiving Esentra 60 mg.
• Breastfeeding: It is not known whether Esentra 60 mg PFS passes into breast milk. If you are breastfeeding and taking Esentra 60 mg it is important to talk to your doctor about the potential risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Esentra 60 mg PFS should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Esentra 60 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Esentra 60 mg PFS may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Esentra 60 mg PFS may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Denosumab Injection 60 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Esentra 60 mg PFS has no or negligible influence on the ability to drive and use machines.